Compare

Amgen vs Moderna

Amgen (AMGN) and Moderna (MRNA) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Amgen AMGNNASDAQ · BiotechnologyModerna MRNANASDAQ · Biotechnology
Insider records, last 12 months146251
Congress trades, last 12 months173
Fund positions reported, last 12 months25933
Federal contract awards, last 12 months00
Open-market purchases by insiders since 200694
Open-market sales by insiders since 20065122,760
Last open-market purchase by an insiderAug 19, 2015Mar 4, 2025
Next resultsNov 3, 2026Oct 29, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Amgen or Moderna?

Since 2006, Amgen insiders reported 9 open-market purchases against 4 for Moderna, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade AMGN or MRNA?

In the last 12 months, members of Congress disclosed 17 trades in Amgen (AMGN) and 3 in Moderna (MRNA), each reported as a value range on a periodic transaction report.

When did insiders last buy AMGN and MRNA?

Amgen: Aug 19, 2015. Moderna: Mar 4, 2025. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Amgen free$9.99 a month, cancel anytime

Amgen pageModerna pageRare insider trades this weekAll comparisons

https://oqro.io/compare/amgn-vs-mrna